Literature DB >> 34104291

The impact of COVID-19 on the tuberculosis control activities in Addis Ababa.

Negussie Wodajo Beyene1,2, Alemu Lakew Sitotaw1, Ben Tegegn3, Kidist Bobosha4.   

Abstract

The first COVID-19 case was reported in Ethiopia on 13th March 2020 and series of announcements of set of measures, proclamation and directives have been enacted to fight the coronavirus pandemic. These have implications for the regular health services including the TB control program. This brief communication assesses the impact of the COVID-19 response on the TB control activities of Addis Ababa health centers based on research project data. We compared the patient flows in pre-COVID-19 period (quarter 1, Q1) and during COVID-19 (quarter 2, Q2 and quarter 3, Q3) of 2020 at 56 health centers in Addis Ababa from all 10 sub-cities per sub-city. The patient flow declined from 3,473 in Q1 to 1,062 in Q2 and 1,074 in Q3, which is a decrease by 62-76% and 52-80% in Q2 and Q3 respectively as compared to that of Q1. In Q2, Kolfe keranio and Kirkos sub-cities recorded the biggest decline (76 and 75% respectively) whereas Yeka sub-city had the least decline (62%). In Q3, Kirkos sub-city had the biggest decline (80%) and Addis ketema sub-city had the lowest (52%). We conclude that the series of measures, state of emergency proclamation and government directives issued to counter the spread of COVID-19 and the public response to these significantly affected the TB control activities in Addis Ababa city as attested by the decrease in the patient flow at the clinics. Health authorities may inform the public that essential health services are still available and open to everyone in need of these services. Copyright: Negussie Wodajo Beyene et al.

Entities:  

Keywords:  Addis Ababa health centers; COVID-19 control measures; tuberculosis control activities

Year:  2021        PMID: 34104291      PMCID: PMC8164422          DOI: 10.11604/pamj.2021.38.243.27132

Source DB:  PubMed          Journal:  Pan Afr Med J


  7 in total

1.  Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria.

Authors:  O O Adewole
Journal:  Int J Tuberc Lung Dis       Date:  2020-09-01       Impact factor: 2.373

2.  Adapting a TB contact investigation strategy for COVID-19.

Authors:  T-A Nguyen; Q N Cuong; A L T Kim; T N Huong; H N Nguyen; G J Fox; G B Marks
Journal:  Int J Tuberc Lung Dis       Date:  2020-05-01       Impact factor: 2.373

3.  Community knowledge, attitudes and practices towards tuberculosis and its treatment in Mpwapwa district, central Tanzania.

Authors:  P E Mangesho; E Shayo; W H Makunde; G B S Keto; C I Mandara; M L Kamugisha; A M Kilale; D R S Ishengoma
Journal:  Tanzan Health Res Bull       Date:  2007-01

Review 4.  Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes.

Authors:  Toyin Togun; Beate Kampmann; Neil Graham Stoker; Marc Lipman
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-05-23       Impact factor: 3.944

Review 5.  TB control in India in the COVID era.

Authors:  D Behera
Journal:  Indian J Tuberc       Date:  2020-08-28

6.  Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study.

Authors:  Alexandra B Hogan; Britta L Jewell; Ellie Sherrard-Smith; Juan F Vesga; Oliver J Watson; Charles Whittaker; Arran Hamlet; Jennifer A Smith; Peter Winskill; Robert Verity; Marc Baguelin; John A Lees; Lilith K Whittles; Kylie E C Ainslie; Samir Bhatt; Adhiratha Boonyasiri; Nicholas F Brazeau; Lorenzo Cattarino; Laura V Cooper; Helen Coupland; Gina Cuomo-Dannenburg; Amy Dighe; Bimandra A Djaafara; Christl A Donnelly; Jeff W Eaton; Sabine L van Elsland; Richard G FitzJohn; Han Fu; Katy A M Gaythorpe; William Green; David J Haw; Sarah Hayes; Wes Hinsley; Natsuko Imai; Daniel J Laydon; Tara D Mangal; Thomas A Mellan; Swapnil Mishra; Gemma Nedjati-Gilani; Kris V Parag; Hayley A Thompson; H Juliette T Unwin; Michaela A C Vollmer; Caroline E Walters; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; Neil M Ferguson; Lucy C Okell; Thomas S Churcher; Nimalan Arinaminpathy; Azra C Ghani; Patrick G T Walker; Timothy B Hallett
Journal:  Lancet Glob Health       Date:  2020-07-13       Impact factor: 26.763

7.  Containment of COVID-19 in Ethiopia and implications for tuberculosis care and research.

Authors:  Hussen Mohammed; Lemessa Oljira; Kedir Teji Roba; Getnet Yimer; Abebaw Fekadu; Tsegahun Manyazewal
Journal:  Infect Dis Poverty       Date:  2020-09-16       Impact factor: 4.520

  7 in total
  5 in total

1.  Real-Time Impact of COVID-19 on Clinical Care and Treatment of Patients with Tuberculosis: A Multicenter Cross-Sectional Study in Addis Ababa, Ethiopia.

Authors:  Dagmawi Chilot; Yimtubezinash Woldeamanuel; Tsegahun Manyazewal
Journal:  Ann Glob Health       Date:  2021-11-15       Impact factor: 2.462

2.  Impact of COVID-19 pandemic on TB prevention and care in Addis Ababa, Ethiopia: a retrospective database study.

Authors:  Balew Arega; Abebe Negesso; Betelhem Taye; Getachew Weldeyohhans; Bekure Bewket; Tesfaye Negussie; Ayele Teshome; Getabalew Endazenew
Journal:  BMJ Open       Date:  2022-02-08       Impact factor: 2.692

Review 3.  A Review of COVID-19 Response Challenges in Ethiopia.

Authors:  Abdulnasir Abagero; Luca Ragazzoni; Ives Hubloue; Francesco Barone-Adesi; Hamdi Lamine; Adamu Addissie; Francesco Della Corte; Martina Valente
Journal:  Int J Environ Res Public Health       Date:  2022-09-04       Impact factor: 4.614

Review 4.  Evidence of TB Services at Primary Healthcare Level during COVID-19: A Scoping Review.

Authors:  Thobeka Dlangalala; Alfred Musekiwa; Alecia Brits; Kuhlula Maluleke; Ziningi Nobuhle Jaya; Kabelo Kgarosi; Tivani Mashamba-Thompson
Journal:  Diagnostics (Basel)       Date:  2021-11-27

Review 5.  Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic.

Authors:  Hung-Jen Tang; Chih-Cheng Lai; Chien-Ming Chao
Journal:  Antibiotics (Basel)       Date:  2022-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.